Department of Surgery, University Hospitals Case Medical Center, Cleveland, OH, USA.
Surgery. 2010 Oct;148(4):893-7; discussion 897-8. doi: 10.1016/j.surg.2010.07.008. Epub 2010 Aug 24.
Diaphragm pacing (DP) can replace mechanical ventilation in tetraplegics and in trials has assisted respiration in amyotrophic lateral sclerosis patients. This report describes results of DP in patients with cardiac pacemakers.
Prospective, single-center and multicenter, nonrandomized, controlled, interventional protocols under U.S. Food and Drug Administration and/or institutional review board approval were evaluated. Patients underwent laparoscopic diaphragm motor point mapping to identify optimal electrode site for implantation. With diaphragm conditioning, patients were weaned from their ventilator. Perioperative and long-term assessments between the cardiac pacemakers and DP were analyzed for any device-to-device interactions.
Over 300 subjects were implanted from 2000 to 2010. Twenty tetraplegics with cardiac pacemakers and DP were analyzed from 6 sites. Subjects ranged from 19 to 61 years old with DP implantation 6 months to 24 years postinjury. There were no immediate or long-term device to device interactions. All patients achieved diaphragm-paced tidal volumes exceeding their basal requirements and, after conditioning, all patients could go >4 hours without mechanical ventilators; 71% could go 24 hours continuously.
DP can be safely implanted in tetraplegics having cardiac pacemakers. Applications for temporary use of DP to maintain diaphragm type 1 muscle fiber and improve posterior lobe ventilation may benefit complex critical care patients.
膈肌起搏(DP)可替代四肢瘫痪患者的机械通气,并在试验中辅助肌萎缩侧索硬化症患者呼吸。本报告介绍了心脏起搏器患者 DP 的结果。
评估了在美国食品和药物管理局(FDA)和/或机构审查委员会批准下进行的前瞻性、单中心和多中心、非随机、对照、干预性方案。患者接受腹腔镜膈肌运动点映射以确定植入的最佳电极位置。在膈肌调理期间,患者从呼吸机中脱机。对心脏起搏器和 DP 之间的围手术期和长期评估进行了分析,以评估任何设备间的相互作用。
2000 年至 2010 年间,共有 300 多名患者接受了植入手术。从 6 个地点分析了 20 例患有心脏起搏器和 DP 的四肢瘫痪患者。受试者年龄从 19 岁到 61 岁,DP 植入后距损伤时间为 6 个月至 24 年。没有立即或长期的设备间相互作用。所有患者的膈肌起搏潮气量均超过其基础需求,并且在调理后,所有患者都可以在没有机械呼吸机的情况下>4 小时;71%的患者可以连续 24 小时。
DP 可安全植入患有心脏起搏器的四肢瘫痪患者。DP 的临时应用可维持膈肌 I 型肌纤维并改善后叶通气,可能有益于复杂的重症监护患者。